Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 01 Sept 2026 for Crinetics Pharmaceuticals, Inc., €8.1M. Read the official filing
Filing timeline
BuySaleRichard Scott Struthers
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Richard Scott Struthers: trading record in brief
This profile gathers the share dealings of Richard Scott Struthers in Crinetics Pharmaceuticals, Inc., where the filings describe the role as chief executive. In total, 44 filings cover trades dated from 7 September 2021 to 1 September 2026.
The open-market record consists of 9 sales worth €4.3M, with no purchase. Other entries cover 7 share grants and 13 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 1 September 2026 with a transaction (€8.1M) in Crinetics Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Richard Scott Struthers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations44 total
111,100 shares@ US$85.000.10% mcap7.4% of flowCommon StockSEC:0001628280-26-059882:7
111,100 shares@ US$85.000.10% mcap7.4% of flowCommon StockSEC:0001628280-26-059882:8
111,100 shares@ US$85.000.10% mcap7.4% of flowCommon StockSEC:0001628280-26-059882:9
111,100 shares@ US$85.000.10% mcap7.4% of flowCommon StockSEC:0001628280-26-059882:6
176,663 shares@ US$85.000.17% mcap11.8% of flowCommon StockSEC:0001628280-26-059882:11
248,043 shares@ US$85.000.23% mcap16.6% of flowCommon StockSEC:0001628280-26-059882:0
1,000 shares@ US$85.000.0009% mcap0.1% of flowCommon StockSEC:0001628280-26-059882:1
136,805 shares@ US$85.000.13% mcap9.1% of flowCommon StockSEC:0001628280-26-059882:2
106,000 shares@ US$85.000.100% mcap7.1% of flowCommon StockSEC:0001628280-26-059882:3
110,000 shares@ US$85.000.10% mcap7.3% of flowCommon StockSEC:0001628280-26-059882:4
100,000 shares@ US$85.000.094% mcap6.7% of flowCommon StockSEC:0001628280-26-059882:5
80,000 shares@ US$85.000.075% mcap5.3% of flowCommon StockSEC:0001628280-26-059882:10
4,422 shares@ US$22.610.0011% mcap1.3% of flowCommon StockSEC:0001628280-26-055700:1
6,542 shares@ US$15.290.0011% mcap1.3% of flowCommon StockSEC:0001628280-26-055700:2
4,995 shares@ US$20.020.0011% mcap1.3% of flowCommon StockSEC:0001628280-26-055700:3
3,969 shares@ US$25.190.0011% mcap1.3% of flowCommon StockSEC:0001628280-26-055700:0
13,196 shares@ US$37.116.7% of flowCommon StockSEC:0001628280-26-019488:0
62,000 shares0Common StockSEC:0001628280-26-011730:0
16,342 shares@ US$9.282.0% of flowCommon StockSEC:0001628280-25-058056:0
4,000 shares@ US$45.002.5% of flowCommon StockSEC:0001658247-25-000011:0
90,400 shares0Common StockSEC:0000950170-25-073605:0
81,270 shares@ US$1.912.3% of flowCommon StockSEC:0000950170-25-051170:0
16,463 shares@ US$34.178.3% of flowCommon StockSEC:0000950170-25-043401:0
89,000 shares0Common StockSEC:0000950170-25-025667:0
10,000 shares@ US$57.578.8% of flowCommon StockSEC:0000950170-24-133297:0
25 of 44 declarations
